Prevention of Pneumococcal Disease in Children 1: The Next Generation of PCV

Title:

Prevention of Pneumococcal Disease in Children 1: The Next Generation of PCV

Topic: Infectious Diseases
Relevant Terms: Childhood Pneumonia, Pneumococcal
Primary Audience: Family Physicians, Pediatricians, Pediatric Nurse Practitioners
Launch Date: 22-Dec-11
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Prevention of Pneumococcal Disease in Children: Optimizing Vaccine Strategies

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Explain the impact of PCV7 on invasive pneumococcal disease in children
  2. Identify the importance of residual pneumococcal disease and the rationale for a next generation PCV

    Faculty

    Stephen Pelton, MD
    Professor of Pediatrics and Epidemiology
    Boston University School of Medicine and Public Health
    Boston, MA
    Tina Q. Tan, MD, FAAP
    Professor of Pediatrics and Pediatric Infectious Diseases
    Feinberg School of Medicine Northwestern University and Children's Memorial Hospital
    Chicago, IL
    Colin D. Marchant, MD
    Associate Professor of Pediatrics
    Boston University School of Medicine
    Boston, MA
    Initiative Description:
    This activity is part of the Prevention of Pneumococcal Disease in Children educational initiative in which the curriculum is designed to improve the management of pediatric pneumococcal disease. The multi-platform design immerses learners in didactic education and case-based vignettes to help raise physician competence and improve patient outcomes. This innovative program includes 3 live workshops, two satellite broadcasts via ReachMD along with this RealCME Virtual Grand Rounds and a Virtual Patient Visit. To learn more and participate in additional activities within this initiative, please visit www.ProvaEducation.com.




     
     
    Accreditation and Credit Designation Statements:
    This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Purdue University College of Pharmacy and Prova Education. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians. 
     
    Purdue University College of Pharmacy designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Target Audience:
    This course is designed to meet the Continuing Medical Education needs of pediatricians and pediatric nurse practitioners, but secondarily include any physician, healthcare provider, or health system that makes decisions and/or administers vaccines to infants or toddlers.

    Faculty Disclosure Statement:  
    All faculty AND staff involved in the planning or presentation of continuing education activities sponsored/provided by Purdue University College of Pharmacy are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. 

    All additional planning committee members, Prova Education and Purdue University College of Pharmacy staff have no relationships to disclose.

    Acknowledgement of Commercial Support:  
    This activity is supported by an independent educational grant from Pfizer.
     
    The following faculty have reported real or apparent conflicts of interest that have been resolved:

    Name of Reviewer/ Planner/ Author Role Reported Areas of Conflict
    Colin D. Marchant, MD Reviewer Research Grant: GlaxoSmithKline, MedImmune, Merck, Novartis, Pfizer
    Consultant/Speaker Bureau: Sanofi Pasteur
    Stephen Pelton, MD Author Research Grant: GSK Biologicals, Intercell, Novartis, Pfizer     
    Advisory Board: GSK Biologicals, Pfizer, Sanofi Pasteur
    Tina Q. Tan, MD, FAAP Reviewer Research Grant: Merck, Sanofi Pasteur                
    Consultant:
    GlaxoSmithKline, Merck, Sanofi Pasteur, Wyeth Pharmaceuticals

    Contact Information
    Prova Education
    877.776.8211
    www.provaeducation.com
    info@provaeducation.com

    Prova Education Privacy Policy
    Prova Education understands how important the privacy of personal information is to our participants. Prova Education is committed to honoring your privacy and to offering special protections for any information you choose to share with us. The information you are reading describes what information we may collect about you, how it may be used, and what precautions we take against unauthorized access or use of your information.
     
    Prova Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your non-public personal information. When you provide us with personally identifiable information, we will take appropriate steps to protect the information you share with us. In this regard, our policy is that we do not give, sell or otherwise transfer your personally identifiable information to anyone outside the Prova Education organization or selected Prova Education partners unless we first disclose to you at the time of collection that your personal information may be provided to third parties. However, there are certain limited instances where we may disclose or transfer personally identifiable information. For example, we may provide such information to appropriate authorities if we believe in good faith that the law requires it or to protect the legal rights or property of Prova Education. Additionally, as we continue to develop our business, we may buy or sell business assets. In such transactions, customer information is generally one of the transferred business assets. However, we are not in the business of selling customer information to others, and aside from certain exceptional circumstances, we will take appropriate measures to ensure the protection of the information you provide to us.